Mj. Clair et al., Angiotensin AT(1) receptor inhibition in pacing induced heart failure: Effects on left ventricular myocardial collagen content and composition, J MOL CEL C, 30(11), 1998, pp. 2355-2364
The progression of left ventricular (LV) dilation with congestive heart fai
lure (CHF) is associated with an increased incidence of morbidity and morta
lity. The LV myocardial extracellular matrix has been implicated to play an
important role in maintaining chamber shape and myocyte alignment. While a
ngiotensin II AT(1) receptor (Ang AT(1)) receptor activation has been demon
strated to contribute to increased vascular resistance with the CHF, whethe
r activation of the myocardial Ang AT(1) receptor system contributes to LV
dilation and myocardial collagen remodelling with CHF remains unclear, The
goal of this study was to examine the effects of Ang AT(1) receptor inhibit
ion on LV geometry and myocardial collagen content and structure with the d
evelopment of pacing CHF. Pigs (25 kg) were instrumented in order to measur
e LV function in the conscious state and were assigned to one of three grou
ps: (1) Pacing CHF: rapid atrial pacing (240 bpm) for 3 weeks (n = 7): (2)
Pacing CHF and Ang AT(1) Block: concomitant: Ang AT(1) receptor blockade (v
alsartan, Novartis, Basel 60 mg/day) and rapid pacing (n=7); (3) sham contr
ols (n=7). The Ang AT(1) receptor antagonist was delivered by osmotic minip
ump and this dose has been demonstrated previously to significantly blunt t
he Ang-II presser response. LV pump function and geometry was assessed by e
chocardiography and LV myocardial collagen content by computer assisted his
tomorphometry and biochemistry, In the pacing CI-IF group, LV fractional sh
ortening was reduced (17+/-2 v 45 +/- 1%) and LV end-diastolic dimension in
creased (5.91 +/- 0.09 v 3.75 +/- 0.07 cm) compared to controls (P<0.05). I
n the pacing CHF and Ang AT(1) blockade group, LV pump function and dimensi
ons were similar to untreated pacing CHF values. The relative content of LV
myocardial fibrillar collagen was reduced with pacing CHF (7.6+/-0.4 v 11.
3+/-0.6%) compared to controls (P<0.05), and was similarly reduced in the p
acing CHF and Ang AT(1) receptor blockade group (8.3+/-0.4%, P<0.05). LV my
ocardial hydroxyproline was reduced with pacing CHF compared to controls (2
.35+/-0.21 v 2.89+/-0.42 mg/gdwt, P<0.05). While reduced with pacing CHF an
d Ang AT(1) receptor blockade (2.54+/-0.25 mg/gdwt), this was not significa
ntly different from controls (P=0.23). Ang AT(1) receptor inhibition in thi
s model of CHF did not appear to favorably affect the degree of LV dilation
and myocardial collagen structure. These results suggest that activation o
f the myocardial Ang AT(1) receptor may not significantly contribute to LV
remodelling with pacing CHF. (C) 1998 Academic Press.